Alzheimer’s Disease Assessment Scale (ADAS)
FREE for use with an Inquisit Lab or Inquisit Web license.Available Test Forms
Alzheimer's Disease Assessment Scale
The Alzheimer's Disease Assessment Scale (ADAS) as originally described in Rosen et al (1984).
References
Search Google Scholar for peer-reviewed, published research using the Inquisit Alzheimer’s Disease Assessment Scale (ADAS).
Rosen, W.G, Mohs, R.C & Davis, K.L. (1984). A new rating scale for Alzheimer’s disease. American Journal of Psychiatry, 141: 1356-1364.
Mohs RC & Cohen L (1988). Alzheimer’s Disease Assessment Scale (ADAS). Psychopharmacology Bulletin, 24: 627-628.
Talwalker, S., Overall, J. E., Srirama, M. K., & Gracon, S. I. (January 01, 1996). Cardinal features of cognitive dysfunction in Alzheimer's disease: a factor-analytic study of the Alzheimer's Disease Assessment Scale. Journal of Geriatric Psychiatry and Neurology, 9, 1, 39-46.
Schultz, R.R, Siviero, M.O, & Bertolucci, P.H.F. (2001). The cognitive subscale of the “Alzheimer’s Disease Assessment Scale” in a Brazilian sample. Brazilian Journal of Medical and Biological Research, 34, 1295-1302.
Mavioglu, H., Gedizlioglu, M., Akyel, S., Aslaner, T., & Eser, E. (January 01, 2006). The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects. International Journal of Geriatric Psychiatry, 21, 3, 259-65.
Tsolaki, M., Alexiadou, A., Kiosseoglou, G., & Kounti, F. (January 01, 2006). Correlations Between the Functional-Cognitive Assessment Scale and the Alzheimer's Disease Assessment Scale When Administered to Patients With Dementia Residing in Long-term Care. American Journal of Alzheimer's Disease and Other Dementias®, 21, 4, 274-280.
Irizarry, M. C., Webb, D. J., Bains, C., Barrett, S. J., Lai, R. Y., Laroche, J. P., Hosford, D., ... Weil, J. G. (January 01, 2008). Predictors of placebo group decline in the Alzheimer's disease Assessment Scale-cognitive subscale (ADAS-Cog) in 24 week clinical trials of Alzheimer's disease. Journal of Alzheimer's Disease : Jad, 14, 3, 301-11.